Related Experiment Videos
The Hemo-matic Analyzer: a new occult blood testing device
The American Journal of Gastroenterology
|February 1, 1984
Summary
The Hemo-matic Analyzer offers a more sensitive and reliable method for fecal occult blood screening compared to traditional guaiac cards. This advanced device simplifies testing by eliminating dietary restrictions and interference from common substances, aiding early colon cancer detection.
Area of Science:
- Clinical diagnostics
- Gastroenterology
- Biomedical engineering
Background:
- Fecal occult blood testing is crucial for early colon cancer detection.
- Traditional guaiac-based tests (e.g., Hemoccult II) have limitations due to strict dietary requirements and interference from various substances.
- A need exists for more sensitive and user-friendly screening methods.
Purpose of the Study:
- To evaluate the sensitivity and performance of the Hemo-matic Analyzer.
- To compare the Hemo-matic Analyzer with the Hemoccult II test for fecal occult blood screening.
- To assess the impact of interfering substances and sample stability on the Hemo-matic Analyzer's performance.
Main Methods:
- In vitro and in vivo evaluation of the Hemo-matic Analyzer's sensitivity.
- Comparative analysis against the Hemoccult II test.
- Assessment of interference from ascorbic acid, plant peroxidase, and red meat.
- Evaluation of sample stability over time.
Main Results:
- The Hemo-matic Analyzer demonstrated approximately six times greater sensitivity than Hemoccult II.
- The device was unaffected by ascorbic acid, plant peroxidase, or red meat ingestion.
- Positive results remained stable for over 10 weeks post-preparation.
- The analyzer's filter electrostatically binds Hb, excluding interfering substances.
Conclusions:
- The Hemo-matic Analyzer is a highly sensitive and robust device for fecal occult blood screening.
- It offers significant advantages over conventional guaiac card tests, including simplified patient compliance and improved accuracy.
- This technology represents a valuable advancement for early colon cancer detection programs.